{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:59Z","timestamp":1707524999333},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.7759\/cureus.34508","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T18:59:23Z","timestamp":1675277963000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction"],"prefix":"10.7759","author":[{"given":"Paulo","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e1tia","family":"Costa-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-3726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock SJ","year":"2013","unstructured":"Pocock SJ, Ariti CA, McMurray JJ, et al.. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013, 34:1404-1413. 10.1093\/eurheartj\/ehs337","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb138412.x","article-title":"Congestive cardiac failure and arrhythmias","volume":"162","author":"Phillips PA","year":"1995","unstructured":"Phillips PA, Burrell LM, Tonkin AM, Johnston CI. Congestive cardiac failure and arrhythmias. Med J Aust. 1995, 162:44-47. 10.5694\/j.1326-5377.1995.tb138412.x","journal-title":"Med J Aust"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1711901","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Cosmi D","year":"2017","unstructured":"Cosmi D, Mariottoni B, Cosmi F. Declining risk of sudden death in heart failure. N Engl J Med. 2017, 377:1793-1794. 10.1056\/NEJMc1711901","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld K","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al.. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022, 43:3997-4126. 10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1412654","article-title":"Neprilysin inhibition for heart failure","volume":"371","author":"Timmis A","year":"2014","unstructured":"Timmis A. Neprilysin inhibition for heart failure. N Engl J Med. 2014, 371:2336. 10.1056\/NEJMc1412654","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai AS","year":"2015","unstructured":"Desai AS, McMurray JJ, Packer M, et al.. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J. 2015, 36:1990-1997. 10.1093\/eurheartj\/ehv186","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz553","article-title":"What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?","volume":"41","author":"Packer M","year":"2020","unstructured":"Packer M. What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?. Eur Heart J. 2020, 41:1757-1763. 10.1093\/eurheartj\/ehz553","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.11.012","article-title":"Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices","volume":"15","author":"de Diego C","year":"2018","unstructured":"de Diego C, Gonz\u00e1lez-Torres L, N\u00fa\u00f1ez JM, et al.. Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm. 2018, 15:395-402. 10.1016\/j.hrthm.2017.11.012","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2018.1473825","article-title":"Impact of sacubitril\/valsartan on heart failure admissions: insights from real-world patient prescriptions","volume":"74","author":"Martens P","year":"2019","unstructured":"Martens P, Lambeets S, Lau CW, Dupont M, Mullens W. Impact of sacubitril\/valsartan on heart failure admissions: insights from real-world patient prescriptions. Acta Cardiol. 2019, 74:115-122. 10.1080\/00015385.2018.1473825","journal-title":"Acta Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101582","article-title":"Impact of sacubitril\/valsartan on the long-term incidence of ventricular arrhythmias in chronic heart failure patients","volume":"8","author":"El-Battrawy I","year":"2019","unstructured":"El-Battrawy I, Pilsinger C, Liebe V, et al.. Impact of sacubitril\/valsartan on the long-term incidence of ventricular arrhythmias in chronic heart failure patients. J Clin Med. 2019, 8:10.3390\/jcm8101582","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20150025","article-title":"Reverse cardiac remodeling: a marker of better prognosis in heart failure","volume":"104","author":"Reis Filho JR","year":"2015","unstructured":"Reis Filho JR, Cardoso JN, Cardoso CM, Pereira-Barretto AC. Reverse cardiac remodeling: a marker of better prognosis in heart failure. Arq Bras Cardiol. 2015, 104:502-506. 10.5935\/abc.20150025","journal-title":"Arq Bras Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi JL Jr","year":"2019","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, et al.. Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA. 2019, 322:1085-1095. 10.1001\/jama.2019.12821","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"322","author":"Desai AS","year":"2019","unstructured":"Desai AS, Solomon SD, Shah AM, et al.. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2019, 322:1077-1084. 10.1001\/jama.2019.12843","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang Y","year":"2019","unstructured":"Wang Y, Zhou R, Lu C, Chen Q, Xu T, Li D. Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis. J Am Heart Assoc. 2019, 8:e012272. 10.1161\/JAHA.119.012272","journal-title":"J Am Heart Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.01.052","article-title":"Prescription of potentially harmful drugs in young adults with heart failure and reduced ejection fraction","volume":"123","author":"Alvarez PA","year":"2019","unstructured":"Alvarez PA, Truong CN, Briasoulis A, Ganduglia-Cazaban C. Prescription of potentially harmful drugs in young adults with heart failure and reduced ejection fraction. Am J Cardiol. 2019, 123:1458-1463. 10.1016\/j.amjcard.2019.01.052","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.04.016","article-title":"Prediction of appropriate shocks using 24-hour Holter variables and T-wave alternans after first implantable cardioverter-defibrillator implantation in patients with ischemic or nonischemic cardiomyopathy","volume":"118","author":"Seegers J","year":"2016","unstructured":"Seegers J, Bergau L, Exp\u00f3sito PM, et al.. Prediction of appropriate shocks using 24-hour Holter variables and T-wave alternans after first implantable cardioverter-defibrillator implantation in patients with ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2016, 118:86-94. 10.1016\/j.amjcard.2016.04.016","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09991-3","article-title":"Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence?","volume":"27","author":"Vecchi AL","year":"2022","unstructured":"Vecchi AL, Abete R, Marazzato J, Iacovoni A, Mortara A, De Ponti R, Senni M. Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence?. Heart Fail Rev. 2022, 27:103-110. 10.1007\/s10741-020-09991-3","journal-title":"Heart Fail Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers SA","year":"2016","unstructured":"Hubers SA, Brown NJ. Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation. 2016, 133:1115-1124. 10.1161\/CIRCULATIONAHA.115.018622","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134752-the-effect-of-sacubitril-valsartan-on-ventricular-arrhythmia-burden-in-patients-with-heart-failure-with-reduced-ejection-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:18Z","timestamp":1707508278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134752-the-effect-of-sacubitril-valsartan-on-ventricular-arrhythmia-burden-in-patients-with-heart-failure-with-reduced-ejection-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.34508","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}